miRecule
miRecule
About

miRecule is an early-stage biotechnology company developing microRNA-based therapeutics to address two of the major challenges in cancer therapy today. Two of the major problems in cancer therapy are accurately classifying patients based on how their unique cancer will respond to a given drug, and treating patients whose cancer initially responds to a drug, but then returns in a drug-resistant form. Its goal at miRecule is to create therapeutic drugs that address these two critical issues simultaneously, through a holistic drug development approach.

Read more
Similar organizations
European Medicines Agency (EMA)
European Medicines Agency (EMA)
GovernmentService Providers
1 open position
Aga Khan Agency for Habitat (AKAH)
Aga Khan Agency for Habitat (AKAH)
Goods SupplierIndependent/NoneWorks & ConstructionService Providers
1 open position

Experience

Contract Awards
Development of a CXCR4 Targeted miR-29b-3p microRNA Mimic to Treat Human Immunodeficiency Virus (HIV)
National Institutes of Health (NIH) - United States, United States Department of Health & Human Services (DHHS)

Company Offices

  • United States (headquarters)
  • Gaithersburg
  • 9119 Gaither Rd